Campoy Carlos
- SEC CIK
- 0001761518
No open-market purchases or sales filed in the past year.
Current role at each company
- ZYME Zymeworks Inc.Directoras of Jan 12, 2026
- CTMX CytomX Therapeutics, Inc.Chief Financial Officeras of Mar 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Campoy Carlos as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CTMX CytomX Therapeutics, Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Campoy CarlosChief Financial Officer | SSale | −1.75K | $1.98 | −$3.46K | −4.4%38.2K after | |
| Jul 21, 2022 (view filing) | Jul 20 | 1 day | Campoy CarlosChief Financial Officer | SSale | −3.95K | $1.42 | −$5.61K | −9.0%40.0K after |